A c-KIT codon 816 mutation, D816H, in the testicular germ cell tumor: Case report of a Japanese patient with bilateral testicular seminomas

Acta Medica Okayama

Volumn 59, Issue 1, 2005, Pages 33-36

  Tate, Genshu ^a   Suzuki, Takao ^a   Kishimoto, Koji ^a   Mitsuya, Toshiyuki ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

c KIT; CD117; Seminoma; Testicular germ cell tumor

Indexed keywords

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; C KIT GENE; CASE REPORT; CODON; DNA SEQUENCE; EUROPE; EXON; GENE; GENE EXPRESSION; GENE MUTATION; GERM CELL TUMOR; HUMAN; JAPAN; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; SEMINOMA; SEQUENCE ANALYSIS;

ADULT; ASPARTIC ACID; BASE SEQUENCE; CODON; HISTIDINE; HUMANS; MALE; MUTATION; NEOPLASMS, SECOND PRIMARY; PROTO-ONCOGENE PROTEINS C-KIT; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 16244384203     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y and Kitamura Y: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science (1998) 279: 577-580.
2. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, Matsuzawa Y, Kitamura Y and Kanakura Y: Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest (1993) 92: 1736-1744.
3. Tian Q, Frierson HF Jr, Krystal GW and Moskaluk CA: Activating c-kit gene mutations in human germ cell tumors. Am J Pahtol (1999) 154: 1643-1647.
4. Strohmeyer T, Reese D, Press M, Ackermann R, Hartmann M and Slamon D: Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol (1995) 153: 511-515.
5. Sakuma Y, Sakurai S, Oguni S, Hironaka M and Saito K: Alterations of the c-kit gene in testicular germ cell tumors. Cancer Sci (2003) 94: 486-491.
6. Looijenga LH, de Leeuw H, van Oorschot M, van Gurp RJ, Stoop H, Gillis AJ, de Gouveia Brazao CA, Weber RF, Kirkels WJ, van Dijk T, von Lindern M, Valk P, Lajos G, Olah E, Nesland JM, Fossa SD and Oosterhuis JW: Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res (2003) 63: 7674-7678.
7. Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A and Heinrich MC: KIT mutations are common in testicular seminomas. Am J Pathol (2004) 164: 305-313.
8. Sakurai S, Oguni S, Hironaka M, Fukayama M, Morinaga S and Saito K: Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese. Jpn J Cancer Res (2001) 92: 494-498.
9. Frost MJ, Ferrao PT, Hughes TP and Ashman LK: Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant. Mol Cancer Ther (2002) 1: 1115-1124.
10. Tate G, Suzuki T and Mitsuya T: A new mutation of LKBI gene in a Japanese patient with Peutz-Jeghers syndrome. Acta Med Okayama (2003) 57: 305-308.
11. Tashiro K, Yanada S, Furuta A, Takizawa A, Iwamuro S, Suzuki M, Hatano T, Kondo N and Ohishi Y: Bilateral germ cell testicular cancer. Rinsho Hinyokika (Jpn J Clin Urol, Tokyo) (2001) 55: 549-552 (in Japanese).
12. Holzbeierlein JM, Sogani PC and Sheinfeld J: Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001. J Urol (2003) 169: 2122-2125.
13. Tian Q, Frierson HF Jr, Krystal GW and Moskaluk CA: Activating c-kit gene mutations in human germ cell tumors. Am J Pathol (1999) 154: 1643-1647.
14. Heinrich MC, Blanke CD, Druker BJ and Corless CL: Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol (2002) 20: 1692-1703.